Amid Brexit broadsides, UK and EU pharma call for calm

13 July 2017
2019_biotech_test_vial_discovery_big

Seven major trade federations representing the pharmaceutical industry in the UK and in Europe have written to Brexit negotiators on both sides of the table urging cooperation on medicines.

The letter comes after UK Foreign Secretary Boris Johnson and lead EU negotiator Michel Barnier engaged in a colorful public war of words in the initial stages of talks.

While the British politician said the EU would have to “go whistle” for a large financial settlement, Mr Barnier retorted he heard, not whistling, “just the clock ticking.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Biotechnology